Biora Therapeutics, Inc. (BIOR)

Biora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5.33	15.21	30.49	88.4	92.08	33.04
Cash & Short-Term Investments	5.33	15.21	30.49	88.4	92.08	33.04
Cash Growth	-79.87%	-50.10%	-65.51%	-4.00%	178.66%	-52.25%
Accounts Receivable	-	-	-	0.65	6.63	22.19
Other Receivables	0.82	0.83	0.83	-	-	0.63
Receivables	0.82	0.83	0.83	0.65	6.63	22.82
Inventory	-	-	-	-	-	10.94
Prepaid Expenses	2.65	2.44	3.63	6.12	8.52	6.48
Other Current Assets	0.41	0.59	3.17	3.6	19.11	1.37
Total Current Assets	9.2	19.07	38.12	98.78	126.34	74.65
Property, Plant & Equipment	2.49	2.77	3.14	3.67	8.11	15.89
Long-Term Investments	-	3	6	-	-	-
Goodwill	6.07	6.07	6.07	6.07	6.07	6.22
Other Intangible Assets	-	-	-	-	-	4.77
Other Long-Term Assets	0.51	0.3	0.2	0.33	13.92	0.2
Total Assets	18.26	31.22	53.53	108.84	154.44	101.73
Accounts Payable	7.51	2.84	3.61	8.71	17.38	15.75
Accrued Expenses	9.44	6.92	4.35	12.23	17.76	17.19
Short-Term Debt	1.68	0.4	0.45	0.49	2.07	-
Current Portion of Long-Term Debt	1.91	1.98	-	-	0.07	0.24
Current Portion of Leases	0.88	0.9	0.89	0.01	0.27	0.73
Current Unearned Revenue	0.03	0.54	0.05	0.3	0.38	-
Other Current Liabilities	24.53	49.39	13.96	39.87	34.75	66.43
Total Current Liabilities	45.99	62.97	23.31	61.61	72.67	100.34
Long-Term Debt	43.77	43.74	127.81	126.39	160.16	72.05
Long-Term Leases	0.4	0.82	0.6	-	0.04	0.36
Other Long-Term Liabilities	17.43	25.11	4.1	5.81	28.56	12.86
Total Liabilities	107.59	132.64	155.81	193.82	261.43	185.6
Common Stock	0.03	0.03	0.01	0.01	0.06	0.01
Additional Paid-In Capital	878.41	868.59	743.63	722.78	452.99	283.26
Retained Earnings	-948.68	-950.96	-826.84	-788.69	-541.27	-348.48
Treasury Stock	-19.08	-19.08	-19.08	-19.08	-18.77	-18.77
Total Common Equity	-89.32	-101.42	-102.29	-84.98	-106.99	-83.98
Shareholders' Equity	-89.32	-101.42	-102.29	-84.98	-106.99	-83.87
Total Liabilities & Equity	18.26	31.22	53.53	108.84	154.44	101.73
Total Debt	48.64	47.83	129.75	126.89	162.61	73.37
Net Cash (Debt)	-43.32	-32.62	-99.26	-38.5	-70.54	-40.33
Net Cash Per Share	-16.55	-20.68	-130.01	-100.09	-640.92	-2064.97
Filing Date Shares Outstanding	3.65	3.03	1.18	0.74	0.24	0.02
Total Common Shares Outstanding	3.59	2.78	0.89	0.73	0.22	0.02
Working Capital	-36.79	-43.9	14.81	37.17	53.67	-25.69
Book Value Per Share	-24.85	-36.43	-114.56	-116.81	-479.60	-4218.62
Tangible Book Value	-95.39	-107.49	-108.36	-91.05	-113.07	-94.97
Tangible Book Value Per Share	-26.54	-38.61	-121.36	-125.15	-506.82	-4770.68
Land	-	-	-	-	0.35	1.09
Buildings	0.85	0.8	0.75	0.44	0.44	9.49
Machinery	2.71	2.42	4.81	8.83	10.34	21.13
Construction In Progress	0	0.05	0.09	0.02	2.77	1.49

Source: S&P Capital IQ. Standard template. Financial Sources.